Bionano Genomics, Inc. (BNGO)

Bionano Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	10.43	17.95	5.09	24.57	38.45	17.31
Short-Term Investments	8.52	48.82	108.1	226.04	-	-
Cash & Short-Term Investments	18.94	66.77	113.19	250.61	38.45	17.31
Cash Growth	-75.42%	-41.01%	-54.84%	551.80%	122.10%	4.77%
Accounts Receivable	6.26	9.32	7.02	4.93	2.78	6.33
Other Receivables	0.1	0.34	0.47	-	-	-
Receivables	6.36	9.66	7.5	4.93	2.78	6.33
Inventory	19.48	22.89	29.76	12.39	3.32	3.44
Prepaid Expenses	4.79	1.1	1.39	4.48	0.64	0.3
Other Current Assets	-	39.69	5.47	-	1.61	0.87
Total Current Assets	60.57	140.12	157.3	272.41	46.79	28.26
Property, Plant & Equipment	32.49	32.48	28.96	20.94	4.91	1.95
Goodwill	-	-	77.29	56.16	7.17	-
Other Intangible Assets	30.02	33.97	41.14	26.84	1.48	-
Other Long-Term Assets	6.29	7.83	2.81	0.75	0.1	-
Total Assets	129.36	214.4	307.5	377.1	60.45	30.21
Accounts Payable	8.73	10.38	12.53	10.77	2.93	2.7
Accrued Expenses	3.8	6.58	9.22	6.94	4.36	2.5
Short-Term Debt	19.36	69.8	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	20.08
Current Portion of Leases	2.41	2.44	2.55	1.77	-	-
Current Income Taxes Payable	1.07	1.1	0.83	0.68	0.56	0.27
Current Unearned Revenue	1.15	0.78	0.87	0.68	0.42	0.36
Other Current Liabilities	0.66	8.94	9.89	1	0.68	0.46
Total Current Liabilities	37.18	100.03	35.88	21.84	8.95	26.37
Long-Term Debt	-	-	-	-	16.33	-
Long-Term Leases	5.81	7.18	9.12	8.93	-	-
Long-Term Unearned Revenue	0.27	0.15	0.13	0.15	0.1	0.18
Other Long-Term Liabilities	5.77	10.89	12.97	9.07	-	0.04
Total Liabilities	49.03	118.25	58.1	39.98	25.37	26.59
Common Stock	0.01	0.01	0	0.03	0.02	0
Additional Paid-In Capital	709.19	677.34	599.23	553.75	178.75	106.19
Retained Earnings	-628.85	-581.21	-348.72	-216.12	-143.68	-102.58
Comprehensive Income & Other	-0	0.02	-1.12	-0.54	-	-
Total Common Equity	80.34	96.16	249.4	337.12	35.08	3.61
Shareholders' Equity	80.34	96.16	249.4	337.12	35.08	3.61
Total Liabilities & Equity	129.36	214.4	307.5	377.1	60.45	30.21
Total Debt	27.57	79.41	11.67	10.7	16.33	20.08
Net Cash (Debt)	-8.63	-12.64	101.52	239.92	22.12	-2.77
Net Cash Growth	-	-	-57.69%	984.42%	-	-
Net Cash Per Share	-0.18	-0.37	3.51	8.67	2.12	-1.85
Filing Date Shares Outstanding	86	54.69	30.62	28.96	27.87	3.78
Total Common Shares Outstanding	70.78	45.75	29.72	28.96	19	3.43
Working Capital	23.39	40.09	121.41	250.57	37.84	1.89
Book Value Per Share	1.14	2.10	8.39	11.64	1.85	1.05
Tangible Book Value	50.32	62.18	130.97	254.12	26.43	3.61
Tangible Book Value Per Share	0.71	1.36	4.41	8.77	1.39	1.05
Machinery	-	38.68	27.11	16.72	10.48	6.35
Leasehold Improvements	-	3.75	4	2.67	1.89	1.88

Source: S&P Capital IQ. Standard template. Financial Sources.